Markets › India › NSE › ANTHEM

Anthem Biosciences Ltd

NSE:ANTHEMHealthcareNSE:CNX500NSE:NIFTY500_EW

₹808.50−1.66%At closeAt close · Mon 19 Oct · ≈ AED 31.19 · Market cap $4.87B · Next earnings Wed 2 Dec

INR billions	FY2021	FY2021	FY2022	FY2023	FY2024	FY2025	YoY
Net income	—	—	—	—	6.6	5.9	−9.9%
Depreciation & amortization	—	0.6	0.6	0.8	0.9	1.3	+50.0%
Stock-based compensation	—	—	—	—	0.3	0.2	−53.8%
Change in working capital	—	(1.4)	(1.0)	(2.6)	(1.5)	1.4	+191.5%
Operating cash flow	—	3.4	3.4	1.8	4.2	9.2	+119.2%
Capital expenditure	—	(1.6)	(1.9)	(3.0)	(3.1)	(2.1)	+32.9%
Acquisitions	—	—	—	—	0.0	0.0	—
Investing cash flow	—	—	—	—	(1.5)	(7.8)	−413.4%
Dividends paid	—	(0.0)	0.0	0.0	0.0	0.0	—
Share buybacks	—	—	—	—	0.0	0.0	—
Debt issued / repaid	—	—	—	—	(1.2)	(0.6)	+53.2%
Financing cash flow	—	—	—	—	(1.3)	(0.3)	+75.2%
Free cash flow	1.8	1.8	1.5	(1.2)	1.0	7.1	+580.7%
Net change in cash	—	—	—	—	1.3	(0.4)	−131.7%

INR billionsUpdated Tue 31 Mar ·

ⓘ

Amounts are shown in the stated units; per-share amounts and shares are unscaled. Negative amounts are in brackets.